Algeria, Germany, Turkey ink 29.9-mln-USD deal to produce hypertension, diabetes drugs

          Source: Xinhua| 2019-01-15 04:26:31|Editor: yan
          Video PlayerClose

          ALGIERS, Jan. 14 (Xinhua) -- The Algerian-Turkish pharmaceuticals company Abdi Ibrahim Remede Pharma (AIRP) on Monday signed a 20-million-euro (29.9-million-U.S. dollar) agreement with its German opposite number Boehringer Ingelheim to produce drugs treating hypertension and diabetes.

          According to the agreement, the medications Micardi.plus (against high blood pressure) and Jardiance (against Type 2 diabetes) will be produced locally.

          The two drugs will be made by AIRP production unit in the new city of Sidi Abdullah in Algiers' western district.

          Bachir Batel, the director general of Boehringer Ingelheim, said the production of drugs to treat tye 2 diabetes will start in the second quarter of 2019, to be available in the second half of 2023.

          He added that the production of hypertension drugs will start by April 2021 and will be available on the Algerian market in the second quarter of 2021.

          For his part, Mohamed Lamine Bousteila, AIRP's representative, said investing 20 million euro in this project comprises equipment, technology transfer and training.

          TOP STORIES
          EDITOR’S CHOICE
          MOST VIEWED
          EXPLORE XINHUANET
          010020070750000000000000011105521377438531
          无码人妻一区二区三区四区av_亚洲精品911在线永久观看_精品一区二区国产在线观看_日韩不卡一区二区视频在线

                  久久综合亚洲色社区 | 亚洲中文字幕在线资源站 | 五月天婷婷综合视频在线观看 | 精品亚洲视频在线 | 香蕉国产线观看免费网站 | 香蕉成人人多人视频 |